Clinical validity of expanded carrier screening: Evaluating the gene-disease relationship in more than 200 conditions.

Authors:
Balzotti M; Meng L; Muzzey D; Johansen Taber K; Beauchamp K and 5 more

Journal:
Hum Mutat

Publication Year: 2020

DOI:
10.1002/humu.24033

PMCID:
PMC7496796

PMID:
32383249

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Hum Mutat

Abbreviation: Hum Mutat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in the development of PubCaseFinder, including the new application programming interface a…
Fujiwara T; Shin JM; Yamaguchi A. (2022) - Transparency Score: 3/6
Beacon v2 and Beacon networks: A "lingua franca" for federated data discovery in biomedical genomic…
Rambla J; Baudis M; Ariosa R and 12 more (2022) - Transparency Score: 3/6
Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in th…
Chen SX; Simpson E; Reiter JL and 1 more (2022) - Transparency Score: 3/6
Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form-associated genes …
Goudal A; Karakachoff M; Lindenbaum P and 19 more (2022) - Transparency Score: 4/6
Clinical exome sequencing-Mistakes and caveats.
Corominas J; Smeekens SP; Nelen MR and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS All authors are current or former employees of Myriad Genetics or Baylor Genetics."

Evidence found in paper:

"Myriad Genetics, Inc.; Baylor Genetics"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025